Inovio Biomedical Income Statement
View: Annual | Quarterly
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Revenue | 0.7 | 0.6 | 3.3 | 0.5 | 0.5 |
| Cost of Goods Sold | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 4.6 | 3.8 | 4.9 | 5.3 | 5.0 |
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Operating Income | (4.1) | (3.3) | (1.8) | (5.0) | (4.8) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.1 | 0.3 | 3.8 | 0.4 | 0.3 |
| Nonoperating Expenses | -- | -- | -- | -- | -- |
| Income Before Taxes | (4.0) | (3.0) | 2.0 | (4.6) | (4.5) |
| Income Taxes | -- | -- | -- | -- | -- |
| Net Income After Taxes | (4.0) | (3.0) | 2.0 | (4.6) | (4.5) |
| Continuing Operations | (4.0) | (3.0) | 2.0 | (4.6) | (4.5) |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | (4.0) | (3.0) | 2.0 | (4.6) | (4.5) |
| Total Net Income | (4.0) | (3.0) | 2.0 | (4.6) | (4.5) |
| Net Profit Margin | -- | -- | 59.0% | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.09) | (0.07) | 0.05 | (0.10) | (0.11) |
| Dividends per Share | -- | -- | -- | -- | -- |





